Christophe Quéva is the founder of Egle Therapeutics. Egle Therapeutics has raised $60M in total funding. Latest round: Growth. Based in Paris, France.
Christophe Quéva is a biotechnology executive who serves as the Chief Executive Officer of Egle Therapeutics, a company based in Paris, France. Egle Therapeutics focuses on developing therapies for immuno-oncology and autoimmune diseases by targeting regulatory T cells. Since its inception in 2020, the company has raised nearly €56 million through equity and non-dilutive public funding.
Full founder directory · Investor directory · Company funding database · Fundraising library